Isofol Medical AB (publ) (STO:ISOFOL)
0.689
-0.004 (-0.51%)
At close: Mar 9, 2026
Isofol Medical AB Balance Sheet
Financials in millions SEK. Fiscal year is January - December.
Millions SEK. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2016 |
|---|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | 2020 - 2016 |
| Cash & Equivalents | 41.99 | 96.16 | 138.15 | 190.53 | 379.45 | Upgrade
|
| Short-Term Investments | 85 | - | - | - | - | Upgrade
|
| Cash & Short-Term Investments | 126.99 | 96.16 | 138.15 | 190.53 | 379.45 | Upgrade
|
| Cash Growth | 32.06% | -30.40% | -27.49% | -49.79% | 226.01% | Upgrade
|
| Accounts Receivable | - | - | - | 0.56 | 1.63 | Upgrade
|
| Other Receivables | 1.42 | 2.14 | 2.43 | 4.42 | 5.57 | Upgrade
|
| Receivables | 1.42 | 2.14 | 2.43 | 4.98 | 7.2 | Upgrade
|
| Prepaid Expenses | 0.99 | 0.12 | 0.01 | 0.39 | 0.51 | Upgrade
|
| Other Current Assets | - | - | - | 13.85 | 7.46 | Upgrade
|
| Total Current Assets | 129.4 | 98.42 | 140.59 | 209.75 | 394.61 | Upgrade
|
| Property, Plant & Equipment | - | - | 0 | 0.09 | 1.75 | Upgrade
|
| Long-Term Investments | - | - | - | 0.05 | - | Upgrade
|
| Other Long-Term Assets | - | - | - | - | 5.01 | Upgrade
|
| Total Assets | 129.4 | 98.42 | 140.6 | 209.89 | 401.36 | Upgrade
|
| Accounts Payable | 2.73 | 2.03 | 1.99 | 7.87 | 17.74 | Upgrade
|
| Accrued Expenses | 17.09 | 16.82 | 15.03 | 40.88 | 54.51 | Upgrade
|
| Current Portion of Leases | - | - | - | - | 1.54 | Upgrade
|
| Other Current Liabilities | 1.09 | 0.98 | 1.23 | 1.79 | 9.23 | Upgrade
|
| Total Current Liabilities | 20.91 | 19.82 | 18.25 | 50.54 | 83.02 | Upgrade
|
| Long-Term Leases | - | - | - | - | 0.11 | Upgrade
|
| Other Long-Term Liabilities | 0.61 | 0.65 | 0.91 | 0.85 | - | Upgrade
|
| Total Liabilities | 21.53 | 20.47 | 19.16 | 51.39 | 83.13 | Upgrade
|
| Common Stock | 8.61 | 4.95 | 4.95 | 4.95 | 4.95 | Upgrade
|
| Additional Paid-In Capital | 1,299 | 1,218 | 1,218 | 1,218 | 1,218 | Upgrade
|
| Retained Earnings | -1,199 | -1,145 | -1,102 | -1,065 | -904.32 | Upgrade
|
| Comprehensive Income & Other | - | 0 | 0 | - | 0 | Upgrade
|
| Shareholders' Equity | 107.87 | 77.95 | 121.43 | 158.5 | 318.23 | Upgrade
|
| Total Liabilities & Equity | 129.4 | 98.42 | 140.6 | 209.89 | 401.36 | Upgrade
|
| Total Debt | - | - | - | - | 1.65 | Upgrade
|
| Net Cash (Debt) | 126.99 | 96.16 | 138.15 | 190.53 | 377.8 | Upgrade
|
| Net Cash Growth | 32.06% | -30.40% | -27.49% | -49.57% | 233.52% | Upgrade
|
| Net Cash Per Share | 0.59 | 0.60 | 0.86 | 1.18 | 3.01 | Upgrade
|
| Filing Date Shares Outstanding | 281.11 | 161.52 | 161.52 | 161.52 | 161.52 | Upgrade
|
| Total Common Shares Outstanding | 281.11 | 161.52 | 161.52 | 161.52 | 161.52 | Upgrade
|
| Working Capital | 108.48 | 78.59 | 122.34 | 159.21 | 311.59 | Upgrade
|
| Book Value Per Share | 0.38 | 0.48 | 0.75 | 0.98 | 1.97 | Upgrade
|
| Tangible Book Value | 107.87 | 77.95 | 121.43 | 158.5 | 318.23 | Upgrade
|
| Tangible Book Value Per Share | 0.38 | 0.48 | 0.75 | 0.98 | 1.97 | Upgrade
|
| Machinery | - | 0.07 | 0.07 | 0.54 | 0.54 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.